Progress of immune checkpoint inhibitors in treatment of hematologic malignancies
10.3760/cma.j.issn.1009-9921.2017.01.001
- VernacularTitle:免疫检查点抑制剂治疗恶性血液系统肿瘤研究进展
- Author:
Donglu ZHAO
;
Jun MA
- Keywords:
Immune checkpoint inhibitors;
Hematologic malignancies;
American Society of Hematology Annual Meeting
- From:
Journal of Leukemia & Lymphoma
2017;26(1):1-2,11
- CountryChina
- Language:Chinese
-
Abstract:
In recent years, immunotherapy has become an indispensable part in treatment of cancer, and the immune checkpoint inhibitors are the focus of attention. In the 58th American Society of Hematology (ASH) Annual Meeting, the application of immune checkpoint inhibitors in hematologic malignancies had been widely concerned. The recent progress of immune checkpoint inhibitors in hematologic malignancies in this annual meeting will be briefly introduced.
